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Background {#jth14367-sec-0008}
==========

Venous thromboembolic (VTE) disease is a major global cause of morbidity and mortality [1](#jth14367-bib-0001){ref-type="ref"}, [2](#jth14367-bib-0002){ref-type="ref"}. An estimated 10 million episodes are diagnosed yearly; over half of these episodes are provoked by hospital admission or procedure and result in significant loss of disability‐adjusted life years [3](#jth14367-bib-0003){ref-type="ref"}. As a result, there has been sustained focus on prevention over the last two decades [4](#jth14367-bib-0004){ref-type="ref"}, [5](#jth14367-bib-0005){ref-type="ref"}, [6](#jth14367-bib-0006){ref-type="ref"}. However, there are still patient groups where the balance of benefit and risk from thromboprophylaxis remains unclear.

Outpatients placed in temporary lower limb immobilization following injury are one such cohort. Approximately 70 000 such patients are discharged from UK emergency departments each year, with an overall symptomatic VTE rate approaching 2% [7](#jth14367-bib-0007){ref-type="ref"}, [8](#jth14367-bib-0008){ref-type="ref"}, [9](#jth14367-bib-0009){ref-type="ref"}. Some of these events are fatal, leading to natural reflection on prevention strategies and occasional coronial recommendations [10](#jth14367-bib-0010){ref-type="ref"}, [11](#jth14367-bib-0011){ref-type="ref"}. Wide variation in practice regarding the use of immobilization (plaster cast, hinged brace or protective boot) and the use of thromboprophylaxis continues for these patients [12](#jth14367-bib-0012){ref-type="ref"}, [13](#jth14367-bib-0013){ref-type="ref"}, [14](#jth14367-bib-0014){ref-type="ref"}. International guidance offers conflicting advice, from no intervention, through pragmatic shared decision making all the way up to *routine* pharmacological thromboprophylaxis [7](#jth14367-bib-0007){ref-type="ref"}, [15](#jth14367-bib-0015){ref-type="ref"}, [16](#jth14367-bib-0016){ref-type="ref"}. This lack of consensus fosters clinical uncertainty.

The low symptomatic VTE event rate, financial implications, opportunity costs and clinical risks of therapy may be cited as reasons to avoid routine thromboprophylaxis. There are several studies that also suggest that in cohorts without overt additional risk factors, the incidence of clinically relevant VTE in immobilized ambulatory patients is negligible [13](#jth14367-bib-0013){ref-type="ref"}, [17](#jth14367-bib-0017){ref-type="ref"}. As such, recent evidence has begun to focus on discrimination through scoring systems and risk assessment models, to promote tailored thromboprophylaxis to those most likely to benefit [18](#jth14367-bib-0018){ref-type="ref"}. Most scores focus on risk factors relevant to inpatients; it is plausible that these same risk factors increase the likelihood of VTE in ambulatory patients with lower limb immobilization, but this has not been formally evaluated.

Despite publication of three risk‐assessment methods for this particular population in the last decade, the derivation and validation of these scoring systems is often unclear [7](#jth14367-bib-0007){ref-type="ref"}, [18](#jth14367-bib-0018){ref-type="ref"}, [19](#jth14367-bib-0019){ref-type="ref"}. Included risk factors are often double counted, attributed 'points\' in a seemingly arbitrary fashion and dichotomized without evidential support. In addition, it is unclear whether these scores are designed to detect all VTEs; 80% of deep vein thromboses (DVTs) can be clinically silent initially, a statistic that perhaps explains embolization accounting for 30% of first VTE presentations [20](#jth14367-bib-0020){ref-type="ref"}. The validity of scoring systems and risk factors therefore varies depending on the use of routine ultrasound to screen for silent DVT as an outcome, or investigation only of those patients with concerning clinical symptoms.

We sought to identify which individual risk factors have been identified within the literature as likely to increase the risk of both asymptomatic and symptomatic VTE in patients with temporary lower limb immobilization. We then looked to compare these identified risk factors to those highlighted within published risk prediction tools, such as the Guidelines in Emergency Medicine Network (GEMNet), Plymouth and Leiden Thrombosis Risk in Plaster‐cast (L‐TRiP‐cast) rules [7](#jth14367-bib-0007){ref-type="ref"}, [18](#jth14367-bib-0018){ref-type="ref"}, [19](#jth14367-bib-0019){ref-type="ref"}.

Methods {#jth14367-sec-0009}
=======

The systematic review was undertaken in accordance with the general principles recommended in the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement [21](#jth14367-bib-0021){ref-type="ref"}. This review was part of a larger project on thromboprophylaxis for lower limb immobilization, which was registered on the PROSPERO international prospective register of systematic reviews (CRD42017058688). The full protocol is available here.

Data sources and search strategy {#jth14367-sec-0010}
--------------------------------

Potentially relevant studies were identified through searches of 10 electronic databases, including MEDLINE (1946 to May 2017), EMBASE (1974 to May 2017) and the Cochrane Library (2017, issue 4). The search strategy used free text and thesaurus terms and combined synonyms relating to the condition (e.g. venous thromboembolism in people with lower limb immobilization) with risk factor assessment or risk prediction modelling terms (used in the searches of MEDLINE, the Cochrane Library and EMBASE only). Searches were supplemented by hand‐searching the reference lists of all relevant studies (including existing systematic reviews), performing a citation search of relevant articles, contacting key experts in the field and undertaking systematic keyword searches of the World Wide Web using the Google search engine. No language or date restrictions were used on any database. Further details on the search strategy can be found in Table [S1](#jth14367-sup-0001){ref-type="supplementary-material"} (supporting information).

Study selection {#jth14367-sec-0011}
---------------

All titles were examined for inclusion by one reviewer (A.P.) and any citations that clearly did not meet the inclusion criteria (e.g. non‐human, unrelated to venous thromboembolism) were excluded. All abstracts and full‐text articles were then examined independently by two reviewers (A.P. and D.H.). Any disagreements in the selection process were resolved through discussion with a third reviewer (S.G.) and included by consensus.

Studies were considered eligible for inclusion if they met the following criteria: (i) any study design that included a measurement of VTE patient outcome (symptomatic and/or asymptomatic); (ii) adults (age over 16 years) requiring temporary immobilization (e.g. leg cast or brace in an ambulatory setting) for an isolated lower limb injury; and (iii) any studies that reported and analyzed data on individual risk factors associated with deep vein thrombosis or pulmonary embolism.

Data extraction and quality assessment {#jth14367-sec-0012}
--------------------------------------

Data relating to study design, methodological quality and outcomes were extracted by one reviewer (A.P.) into a standardized data extraction form and independently checked for accuracy by a second reviewer (D.H.). Any discrepancies were resolved through discussion to achieve agreement. Where differences were unresolved, a third reviewer\'s opinion was sought (S.G.).

The methodological quality of each included study was assessed using the Risk Of Bias In Non‐randomized Studies ‐ of Interventions tool (ROBINS‐I, formerly called A Cochrane Risk of Bias Assessment Tool ‐ for Non‐Randomized Studies of Interventions, ACROBAT‐NRSI) [22](#jth14367-bib-0022){ref-type="ref"}. The tool is based on the original Cochrane risk of bias tool for randomized studies [23](#jth14367-bib-0023){ref-type="ref"} and also builds on related tools such as QUADAS‐2 (Quality Assessment of Diagnostic Accuracy Studies) [24](#jth14367-bib-0024){ref-type="ref"}. ROBINS‐I [22](#jth14367-bib-0022){ref-type="ref"} provides a detailed framework for assessment and judgement of risk of bias domains, and has been used previously within the systematic review literature [25](#jth14367-bib-0025){ref-type="ref"}.

All studies were analyzed using this tool [22](#jth14367-bib-0022){ref-type="ref"} regardless of whether the original study design included randomization to other exposures, thus ensuring that risk of bias was assessed specifically for the comparisons of interest to this review. It is important to note that the quality assessment reflects how well a specific result evaluated the association of interest to this review, regardless of the objectives of the original study.

Data synthesis and analysis {#jth14367-sec-0013}
---------------------------

We considered VTE to comprise any subsequent recorded diagnosis of asymptomatic or symptomatic deep vein thrombosis, pulmonary embolism or death attributable to either pathology. We made no attempt to distinguish between anatomical location, thrombus burden or clinical sequelae of VTE for this project, in accordance with the definitions of hospital‐acquired thrombosis produced by NHS England (any VTE occurring during hospital admission or up to 90 days after admission) [26](#jth14367-bib-0026){ref-type="ref"}. Individual risk factors highlighted through regression, odds ratio analysis or parametric testing as being significantly associated with an increased or decreased likelihood of subsequent VTE were extracted. In particular, we searched each paper for evidence of individual risk factors highlighted within current risk stratification tools and recorded their prediction performance when addressed. Other risk factors demonstrating an association with asymptomatic or symptomatic VTE in the context of individual studies were also reported. We were unable to perform meta‐analysis as a result of significant levels of heterogeneity between studies, variable reporting items and the high risk of attributable bias. Descriptive statistics and thematic analysis were used to synthesize risk factors acting in a reproducible fashion across studies. All analyses were conducted using Microsoft Excel 2010 (Microsoft Corporation, Redmond, WA, USA).

Results {#jth14367-sec-0014}
=======

Figure [1](#jth14367-fig-0001){ref-type="fig"} summarizes the process of identifying and selecting relevant literature. Of 4771 citations, 75 full‐text articles were retrieved and fully assessed; 15 of these studies met all inclusion criteria [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [29](#jth14367-bib-0029){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}. A list of the 60 excluded studies following full‐text review, with reasons for exclusion, is presented in Table [S2](#jth14367-sup-0002){ref-type="supplementary-material"}.

![Flow chart of abstract screening, exclusion and final selection.](JTH-17-329-g001){#jth14367-fig-0001}

The design and patient characteristics of the included studies [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [29](#jth14367-bib-0029){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"} are summarized in Table [1](#jth14367-tbl-0001){ref-type="table"}. All studies were published between 1993 and 2017. Five were RCTs with conservative arms [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}, three were prospective observational cohort or cross‐sectional studies [30](#jth14367-bib-0030){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, one was a case--control study [39](#jth14367-bib-0039){ref-type="ref"} and six were retrospective cohort studies [29](#jth14367-bib-0029){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, conducted in 10 different countries (Australia [29](#jth14367-bib-0029){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, Canada [28](#jth14367-bib-0028){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, China [41](#jth14367-bib-0041){ref-type="ref"}, Denmark [40](#jth14367-bib-0040){ref-type="ref"}, France [38](#jth14367-bib-0038){ref-type="ref"}, Germany [27](#jth14367-bib-0027){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, Iran [35](#jth14367-bib-0035){ref-type="ref"}, the Netherlands [39](#jth14367-bib-0039){ref-type="ref"}, the UK [31](#jth14367-bib-0031){ref-type="ref"} and the USA [37](#jth14367-bib-0037){ref-type="ref"}). The vast majority of the studies (*n* = 11) were entirely outpatient based [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [29](#jth14367-bib-0029){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}, and the remaining studies [34](#jth14367-bib-0034){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"} included patients with a short‐duration inpatient stay to facilitate day‐case surgery. In total, data were collated on 80 678 patients with a subsequent reported outcome of VTE positive or negative following temporary lower limb immobilization. The median prevalence of any VTE from the studies was 4.8% (ranging from 0.22% [31](#jth14367-bib-0031){ref-type="ref"} to 23.5% [34](#jth14367-bib-0034){ref-type="ref"}) and the mean age ranged from 33.8 years [32](#jth14367-bib-0032){ref-type="ref"} to 52.6 years [40](#jth14367-bib-0040){ref-type="ref"}. The proportion of male subjects ranged from 45.8% [30](#jth14367-bib-0030){ref-type="ref"} to 86.1% [34](#jth14367-bib-0034){ref-type="ref"}, with a median across the studies of 56.3%. The median prevalence of symptomatic VTE only across all studies with interpretable outcome data (77 261 patients) was 2.9%.

###### 

Summary of design and patient characteristics

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year, country                          Design, setting                                                  Inclusion criteria (main)                                                                                                         Patients, sex, age (years)                              Incidence of VTE       Prophylaxis                                                Duration of follow‐up                                                             Risk factor ascertainment                                                       Outcome ascertainment                                                                   Statistical analysis
  ---------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------- ---------------------- ---------------------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- ----------------------------------------------------------
  Gehling *et al*., 1998, Germany                Design: prospective open‐label RCT\                              Age \> 16 years with lower limb injury requiring immobilization with plaster or bandages (and at least one risk factor for VTE)   *n* = 287,\                                             LMWH group: 6.3%\      NR                                                         NR                                                                                Physician assessment (prospective)                                              Clinical assessment, screening sonography and confirmation phlebography                 NR (appears descriptive)
                                                 Setting: outpatient                                                                                                                                                                                50.5% male,\                                            Aspirin group: 4.8%                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                    mean age 36.3[\*](#jth14367-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                               

  Goel *et al*., 2009, Canada                    Design:\                                                         Adults 18--75 years with unilateral displaced fractures below the knee requiring operative intervention                           *n* = 238,\                                             LMWH group: 8.7%\      No prophylaxis prior to randomization                      Minimum of 3 months following surgery or until the fracture had united            Physician assessment (prospective)                                              Clinical assessment and bilateral lower leg venography for all patients                 Univariate and multivariate logistic regression
                                                 prospective double‐blind RCT\                                                                                                                                                                      62% male,\                                              Control group: 12.6%                                                                                                                                                                                                                                                                                                                        
                                                 Setting: outpatient                                                                                                                                                                                mean age 40.5[\*](#jth14367-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                               

  Kock *et al*., 1995, Germany                   Design:\                                                         Adults 18--65 years undergoing conservative treatment for below knee injury with cylinder or below knee cast                      *n* = 339,\                                             LMWH group: 0%\        No prophylaxis prior to randomization                      NR (however, duration of cast: LMWH group, 15.2 days; control group, 18.8 days)   Physician assessment (prospective)                                              Clinical assessment, screening sonography and confirmation phlebography                 NR (appears descriptive)
                                                 prospective open‐label RCT\                                                                                                                                                                        61% male,\                                              Control group: 4.3%                                                                                                                                                                                                                                                                                                                         
                                                 Setting: outpatient                                                                                                                                                                                mean age 33.8[\*](#jth14367-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                               

  Kujath *et al*., 1993, Germany                 Design: prospective open‐label RCT\                              Age \> 16 years undergoing conservative treatment for lower limb injury with below knee plaster applied for \> 7 days             *n* = 253,\                                             LMWH group: 4.8%\      No prophylaxis prior to randomization                      NR\                                                                               Physician assessment (prospective)                                              Compression ultrasound by two examiners and confirmation phlebography                   NR (appears descriptive)
                                                 Setting: outpatient                                                                                                                                                                                58% male,\                                              Control group: 16.5%                                                              (however, duration of cast: LMWH group, 15.6 days; control group, 15.8 days)                                                                                                                                                                              
                                                                                                                                                                                                                                                    mean age 34.3[\*](#jth14367-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                               

  Zheng *et al*., 2017, China                    Design:\                                                         Adults \> 18 years with any fracture of the lower limb requiring operative treatment                                              *n* = 814,\                                             LMWH group: 1.5%\      No prophylaxis prior to randomization                      3 months                                                                          Physician assessment (prospective)                                              Blinded bilateral Doppler compression ultrasound                                        Logistic regression
                                                 prospective double‐blind RCT\                                                                                                                                                                      62.3% male,\                                            Control group: 3.2%                                                                                                                                                                                                                                                                                                                         
                                                 Setting: outpatient                                                                                                                                                                                mean age 47.8                                                                                                                                                                                                                                                                                                                                                                                       

  Riou *et al*., 2007,\                          Design: prospective cohort study\                                Age \> 18 years with isolated lower limb injury (below the knee) managed conservatively (immobilization duration \> 7 days)       *n* = 2761,\                                            6.4%                   Antithrombotic prophylaxis was given to 61% of patients    3 months                                                                          Physician assessment (prospective)                                              Adjudication committee                                                                  Logistic regression with propensity score analysis
  France                                         Setting:\                                                                                                                                                                                          51% male,\                                                                                                                                                                                                                                                                                                                                                                                          
                                                 outpatient                                                                                                                                                                                         mean age 40                                                                                                                                                                                                                                                                                                                                                                                         

  Hanslow *et al*., 2006, Australia              Design:\                                                         Patients who had an operative intervention to the foot or ankle                                                                   *n* = 602,\                                             5.3%                   Antithrombotic prophylaxis was given to 31% of patients    4.4 months                                                                        Collected from clinical records (retrospective)                                 Case note search, including hospital re‐attendance and diagnostic imaging               Logistic regression
                                                 retrospective cohort study\                                                                                                                                                                        52% male,\                                                                                                                                                                                                                                                                                                                                                                                          
                                                 Setting:\                                                                                                                                                                                          mean age 42.9                                                                                                                                                                                                                                                                                                                                                                                       
                                                 outpatient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Jameson *et al*., 2014, UK                     Design:\                                                         Patients with isolated unilateral closed ankle fracture managed conservatively                                                    *n* = 14 777,\                                          0.22% (PE only)        No data recorded                                           3 months                                                                          NR; assumed collected from clinical ecords (retrospective)                      Inpatient mortality or coded diagnosis of pulmonary embolism within 90 days of injury   Logistic regression
                                                 retrospective cohort study\                                                                                                                                                                        47% male,\                                                                                                                                                                                                                                                                                                                                                                                          
                                                 Setting:\                                                                                                                                                                                          mean age, 46.4                                                                                                                                                                                                                                                                                                                                                                                      
                                                 outpatient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Makhdom *et al*., 2013, Canada                 Design:\                                                         All patients undergoing Achilles tendon repair                                                                                    *n* = 115,\                                             23.5%                  No peri‐ or postoperative prophylaxis                      3 months                                                                          Collected from electronic medical record system (retrospective)                 Case note search, including hospital re‐attendance and diagnostic imaging               Non‐parametric testing using Fisher\'s exact test
                                                 retrospective cohort study\                                                                                                                                                                        86.1% male,\                                                                                                                                                                                                                                                                                                                                                                                        
                                                 Setting:\                                                                                                                                                                                          mean age 41                                                                                                                                                                                                                                                                                                                                                                                         
                                                 outpatient until surgery, short day‐case stay thereafter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Meek & Tong, 2012, Australia                   Design:\                                                         Age \> 18 years with acute lower limb injury requiring temporary immobilization (ED discharge within 24 hours of presentation)    *n* = 1231,\                                            2.9%                   No prophylaxis (excluded if received at any dose)          NR                                                                                Electronic notes screened for eligibility by one investigator (retrospective)   Case note search, including hospital re‐attendance and diagnostic imaging               Logistic regression
                                                 retrospective cohort study\                                                                                                                                                                        56.3% male,\                                                                                                                                                                                                                                                                                                                                                                                        
                                                 Setting:\                                                                                                                                                                                          mean age 37                                                                                                                                                                                                                                                                                                                                                                                         
                                                 outpatient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Patel *et al*., 2012, USA                      Design:\                                                         All patients who had Achilles tendon rupture                                                                                      *n* = 1172,\                                            0.77%                  Nil routine, assumed to be none provided                   3 months                                                                          Collected from electronic medical record system (retrospective)                 Case note search, including hospital re‐attendance and diagnostic imaging               Logistic regression
                                                 retrospective cohort study\                                                                                                                                                                        sex NR,\                                                                                                                                                                                                                                                                                                                                                                                            
                                                 Setting:\                                                                                                                                                                                          mean age, 45                                                                                                                                                                                                                                                                                                                                                                                        
                                                 mostly outpatient, some with short inpatient stays (\< 3 days)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Wahlsten *et al*., 2015, Denmark               Design:\                                                         Age \> 18 years undergoing an\                                                                                                    *n* = 57 619,\                                          1.0%                   Routine perioperative prophylaxis with nil postoperative   180 days                                                                          Collected from five different cross‐linked registries (retrospective)           Case note search, including hospital re‐attendance and diagnostic imaging               Multivariate Cox regression
                                                 retrospective cohort study\                                      operative procedure for a fracture of the foot, ankle, tibia or patella                                                           51.4% male,\                                                                                                                                                                                                                                                                                                                                                                                        
                                                 Setting:\                                                                                                                                                                                          mean age 52.6[\*](#jth14367-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                               
                                                 inpatient or outpatient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  van Adrichem *et al*., 2014, the Netherlands   Design:\                                                         Age 18--70 years with a first VTE identified at an anticoagulation clinic (cases)\                                                *n* = 10 567,[†](#jth14367-note-0004){ref-type="fn"}\   NR                     No data recorded                                           3 months                                                                          Participant completed questionnaire (prospective collection)                    Case note search, including hospital re‐attendance and diagnostic imaging               Logistic regression
                                                 case--control study\                                             Control group identified by random dialing method (matched for sex and age)                                                       sex NR,\                                                                                                                                                                                                                                                                                                                                                                                            
                                                 Setting:\                                                                                                                                                                                          mean age NR                                                                                                                                                                                                                                                                                                                                                                                         
                                                 mostly outpatient, some with short inpatient stays (\< 3 days)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Ho & Omari, 2017, Australia                    Design:\                                                         Age \> 18 years with fracture to foot/ankle with conservative management                                                          *n* = 72,\                                              11%                    Nil routine, assumed to be none provided                   6 months                                                                          Questionnaire (unclear if physician or patient completed)                       Prospective compression ultrasound                                                      Parametric and non‐parametric testing with bootstrapping
                                                 cross‐sectional study\                                                                                                                                                                             45.8% male,\                                                                                                                                                                                                                                                                                                                                                                                        
                                                 Setting: outpatient                                                                                                                                                                                mean age NR (median 38)                                                                                                                                                                                                                                                                                                                                                                             

  Manafi Rasi *et al*., 2012, Iran               Design:\                                                         Age \> 15 years with stable foot/ankle fracture or grade 3 sprain (non‐surgical treatment)                                        *n* = 95,\                                              3%                     NR                                                         7--14 days                                                                        NR                                                                              Compression ultrasound by two independent examiners                                     NR (appears descriptive)
                                                 cross‐sectional study\                                                                                                                                                                             77.9% male,\                                                                                                                                                                                                                                                                                                                                                                                        
                                                 Setting:\                                                                                                                                                                                          mean age 38                                                                                                                                                                                                                                                                                                                                                                                         
                                                 outpatient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ED, emergency department; LMWH, low‐molecular‐weight heparin; NR, not reported; RCT, randomized controlled trial; VTE, venous thromboembolism. \*Data calculated based on mean of means. †Sample included 4418 cases and 6149 controls (of these, only 227 cases and 76 controls had lower extremity injuries).
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The duration of follow‐up varied between studies. Ten studies reported follow‐up over a period of at least 3 months [28](#jth14367-bib-0028){ref-type="ref"}, [29](#jth14367-bib-0029){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"} and one study followed‐up patients for up to 14 days [35](#jth14367-bib-0035){ref-type="ref"}. Although four studies failed to record the duration of follow‐up [27](#jth14367-bib-0027){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, two of these appeared to report follow‐up only for the duration of the plaster cast, which averaged 15.7 days [33](#jth14367-bib-0033){ref-type="ref"} and 17 days [32](#jth14367-bib-0032){ref-type="ref"}, respectively. Eight studies collected data on risk factors prospectively via physician assessment or questionnaire [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"} and six studies collected these data through clinical records, electronic patient notes or registry information [29](#jth14367-bib-0029){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}. One study did not report the methodology for this aspect of data collection [35](#jth14367-bib-0035){ref-type="ref"}. Analysis and methodology of VTE diagnosis subsequent to immobilization varied between studies, including prospective screening in all patients following plaster removal (seven studies) [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}, adjudicated diagnostic evaluation in those with symptoms (two studies) [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"} and retrospective identification of VTE through interrogation of clinical records/health databases (six studies) [29](#jth14367-bib-0029){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}. A single study [31](#jth14367-bib-0031){ref-type="ref"} looked only at the subsequent diagnosis of pulmonary embolism as an outcome, with predictably reduced prevalence. The association of individual risk factors with subsequent VTE was assessed through regression analyses (nine studies) [28](#jth14367-bib-0028){ref-type="ref"}, [29](#jth14367-bib-0029){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}, non‐parametric tests (two studies) [30](#jth14367-bib-0030){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"} and descriptive statistics (four studies) [27](#jth14367-bib-0027){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}.

The overall methodological quality of the 15 included studies is summarized in Fig. [2](#jth14367-fig-0002){ref-type="fig"} and Table [2](#jth14367-tbl-0002){ref-type="table"}. All studies were deemed to be at overall moderate (seven studies) [27](#jth14367-bib-0027){ref-type="ref"}, [28](#jth14367-bib-0028){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"} or serious (eight studies) [29](#jth14367-bib-0029){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [35](#jth14367-bib-0035){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"} risk of bias, using the ROBINS‐I [22](#jth14367-bib-0022){ref-type="ref"} framework for assessment and judgement. Studies scoring as at serious risk of bias did so predominately on selection of participants into the study, perhaps highlighting the issue with retrospective observational work on VTE outcomes; patients deemed to be at high risk in these cohorts are often individually treated with thromboprophylaxis (as highlighted in Table [1](#jth14367-tbl-0001){ref-type="table"}) or managed in a different manner to other patients, thus reducing the overall reported risk in the population.

![ROBINS‐I risk of bias assessment graph.](JTH-17-329-g002){#jth14367-fig-0002}

###### 

ROBINS‐I risk of bias assessment summary: review authors\' judgements about each methodological quality item for each included study

  Study                         Bias due to confounding   Bias in selection of participants into the study   Bias in classification/measurement of interventions   Bias because of deviations from intended interventions   Bias because of missing data   Bias in measurement of outcomes   Bias in election of the reported result   Overall[\*](#jth14367-note-0005){ref-type="fn"}
  ----------------------------- ------------------------- -------------------------------------------------- ----------------------------------------------------- -------------------------------------------------------- ------------------------------ --------------------------------- ----------------------------------------- -------------------------------------------------
  Gehling *et al*., 1998        Low                       Low                                                Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Moderate
  Goel *et al*., 2009           Low                       Low                                                Low                                                   Low                                                      Low                            Low                               Moderate                                  Moderate
  Kock *et al*., 1995           Low                       Low                                                Moderate                                              Moderate                                                 Low                            Moderate                          Moderate                                  Moderate
  Kujath *et al*., 1993         Low                       Low                                                Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Moderate
  Zheng *et al*., 2017          Low                       Moderate                                           Low                                                   Low                                                      Moderate                       Low                               Moderate                                  Moderate
  Riou *et al*., 2007           Moderate                  Moderate                                           Moderate                                              Serious                                                  Moderate                       Moderate                          Moderate                                  Serious
  Hanslow *et al*., 2006        Moderate                  Moderate                                           Moderate                                              Serious                                                  Moderate                       Moderate                          Moderate                                  Serious
  Jameson *et al*., 2014        Moderate                  Serious                                            Moderate                                              Serious                                                  Moderate                       Moderate                          Moderate                                  Serious
  Makhdom *et al*., 2013        Serious                   Serious                                            Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Serious
  Meek & Tong, 2012             Moderate                  Serious                                            Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Serious
  Patel *et al*., 2012          Moderate                  Moderate                                           Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Moderate
  Wahlsten *et al*., 2015       Moderate                  Moderate                                           Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Moderate
  van Adrichem *et al*., 2014   Moderate                  Serious                                            Serious                                               Serious                                                  Moderate                       Moderate                          Moderate                                  Serious
  Ho & Omari, 2017              Serious                   Serious                                            Moderate                                              Moderate                                                 Serious                        Moderate                          Moderate                                  Serious
  Manafi Rasi *et al*., 2012    Serious                   Moderate                                           Moderate                                              Moderate                                                 Moderate                       Moderate                          Moderate                                  Serious

Overall risk of bias judgement (equal to the most severe level of bias found in any domain) was judged as: (i) low risk of bias, study comparable to a well‐performed randomized trial; (ii) moderate risk of bias, sound for a non‐randomized study but not comparable to a rigorous randomized trial; (iii) serious risk of bias, the study has some important problems; (iv) critical risk of bias, too problematic to provide any useful evidence on the effects of intervention.
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Age was the most consistent individual risk prediction factor for any VTE outcome, highlighted across 11 studies [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}. Odds ratios reported for age varied from 1.05 [41](#jth14367-bib-0041){ref-type="ref"} to 3.48 [36](#jth14367-bib-0036){ref-type="ref"} with limited estimates of precision. Injury type as a risk factor was highlighted across six studies [28](#jth14367-bib-0028){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, all using multivariate logistic regression to suggest that severe traumatic injuries and fractures (when compared to soft tissue injuries) were independently associated with increased risk of VTE. Body mass index (BMI) was the third most consistent individual risk highlighted, noted as independently predictive of VTE across four studies [33](#jth14367-bib-0033){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}, [41](#jth14367-bib-0041){ref-type="ref"}, with odds ratios ranging from 1.2 [41](#jth14367-bib-0041){ref-type="ref"} to 17.2 [39](#jth14367-bib-0039){ref-type="ref"}. However, six studies looked for and found no association between BMI and subsequent VTE [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}.

Both age and BMI feature in the published and most widely used risk prediction models. Injury type and severity are featured in the L‐TRIP and Plymouth score, but not incorporated within the GEMNET guideline as an individual feature. All individual risk factors currently used within the above risk stratification tools and their reported association with VTE across all included studies, are shown in Table [3](#jth14367-tbl-0003){ref-type="table"}. Despite being present within several risk stratification tools, pregnancy, recent hospital admission and preceding immobility as individual characteristics were not identified and prospectively/retrospectively assessed by any of the included studies. As such, these risk factors do not appear to have been evaluated in the literature regarding association with subsequent VTE, in patients with temporary lower limb immobilization after injury.

###### 

Individual risk factors and their reported strength of association with developing VTE

  Study                                                                                             Risk factors associated with developing VTE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  ------------------------------------------------------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- --------------------------------------------- ----- ---------------------------------------------------- --------------------------------------------- --------------------------------------------- ---------------------------------------------------- --------------------------------------------- ---------------------------------------------------- ----- ----- --------------------------------------------- --------------------------------------------- ---------------------------------------------
  Using an endpoint of asymptomatic VTE, detected by routine screening                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Gehling *et al*., 1998                                                                            N/A                                                  N/A                                                  N/A                                           N/A   N/A                                                  N/A                                           N/A                                           N/A                                                  N/A                                           N/A                                                  N/A   N/A   N/A                                           N/A                                           N/A
  Goel *et al*., 2009                                                                               PSAR[a](#jth14367-note-0006){ref-type="fn"}          NSAR[a](#jth14367-note-0006){ref-type="fn"}          NSAR[a](#jth14367-note-0006){ref-type="fn"}   N/A   NSAR[a](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A                                           NSAR[a](#jth14367-note-0006){ref-type="fn"}          NSAR[a](#jth14367-note-0006){ref-type="fn"}   NSAR[a](#jth14367-note-0006){ref-type="fn"}          N/A   N/A   PSAR[a](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A
  Kock *et al*., 1995                                                                               PSAR[b](#jth14367-note-0006){ref-type="fn"}          NSAR[b](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   NSAR[b](#jth14367-note-0006){ref-type="fn"}          NSAR[b](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A                                                  N/A                                           NSAR[b](#jth14367-note-0006){ref-type="fn"}          N/A   N/A   PSAR[b](#jth14367-note-0006){ref-type="fn"}   PSAR[b](#jth14367-note-0006){ref-type="fn"}   N/A
  Kujath *et al*., 1993                                                                             PSAR[c](#jth14367-note-0006){ref-type="fn"}          PSAR[c](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   N/A                                                  PSAR[c](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A                                                  N/A                                           N/A                                                  N/A   N/A   PSAR[c](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A
  Zheng *et al*., 2017                                                                              PSAR[d](#jth14367-note-0006){ref-type="fn"}          PSAR[d](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   N/A                                                  N/A                                           N/A                                           NSAR[d](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A                                                  N/A   N/A   N/A                                           NSAR[d](#jth14367-note-0006){ref-type="fn"}   N/A
  Ho & Omari, 2017                                                                                  PSAR[e](#jth14367-note-0006){ref-type="fn"}          NSAR[e](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   NSAR[e](#jth14367-note-0006){ref-type="fn"}          N/A                                           NSAR[e](#jth14367-note-0006){ref-type="fn"}   N/A                                                  N/A                                           NSAR[e](#jth14367-note-0006){ref-type="fn"}          N/A   N/A   N/A                                           NSAR[e](#jth14367-note-0006){ref-type="fn"}   NSAR[e](#jth14367-note-0006){ref-type="fn"}
  Manafi Rasi *et al*., 2012                                                                        N/A                                                  N/A                                                  N/A                                           N/A   N/A                                                  N/A                                           N/A                                           N/A                                                  N/A                                           N/A                                                  N/A   N/A   N/A                                           N/A                                           N/A
  Using an endpoint of symptomatic VTE, detected by clinical follow‐up and targeted investigation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Riou *et al*., 2007                                                                               PSAR[f](#jth14367-note-0006){ref-type="fn"}          NSAR[f](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   NSAR[f](#jth14367-note-0006){ref-type="fn"}          NSAR[f](#jth14367-note-0006){ref-type="fn"}   NSAR[f](#jth14367-note-0006){ref-type="fn"}   NSAR[f](#jth14367-note-0006){ref-type="fn"}          N/A                                           NSAR[f](#jth14367-note-0006){ref-type="fn"}          N/A   N/A   PSAR[f](#jth14367-note-0006){ref-type="fn"}   PSAR[f](#jth14367-note-0006){ref-type="fn"}   PSAR[f](#jth14367-note-0006){ref-type="fn"}
  Hanslow *et al*., 2006                                                                            N/A                                                  N/A                                                  N/A                                           N/A   N/A                                                  N/A                                           PSAR[g](#jth14367-note-0006){ref-type="fn"}   PSAR[g](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A                                                  N/A   N/A   N/A                                           PSAR[g](#jth14367-note-0006){ref-type="fn"}   PSAR[g](#jth14367-note-0006){ref-type="fn"}
  Jameson *et al*., 2014                                                                            NSAR[h](#jth14367-note-0006){ref-type="fn"}          N/A                                                  N/A                                           N/A   N/A                                                  N/A                                           N/A                                           PSAR[h](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A                                                  N/A   N/A   N/A                                           N/A                                           N/A
  Makhdom *et al*., 2013                                                                            PSAR[\[Link\]](#jth14367-note-0006){ref-type="fn"}   NSAR[\[Link\]](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A   NSAR[\[Link\]](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A                                           NSAR[\[Link\]](#jth14367-note-0006){ref-type="fn"}   N/A                                           NSAR[\[Link\]](#jth14367-note-0006){ref-type="fn"}   N/A   N/A   N/A                                           N/A                                           N/A
  Meek & Tong, 2012                                                                                 PSAR[j](#jth14367-note-0006){ref-type="fn"}          N/A                                                  N/A                                           N/A   N/A                                                  N/A                                           N/A                                           N/A                                                  N/A                                           N/A                                                  N/A   N/A   PSAR[j](#jth14367-note-0006){ref-type="fn"}   NSAR[j](#jth14367-note-0006){ref-type="fn"}   N/A
  Patel *et al*., 2012                                                                              PSAR[k](#jth14367-note-0006){ref-type="fn"}          NSAR[k](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   N/A                                                  N/A                                           NSAR[k](#jth14367-note-0006){ref-type="fn"}   NSAR[k](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A                                                  N/A   N/A   N/A                                           N/A                                           N/A
  Wahlsten *et al*., 2015                                                                           PSAR[l](#jth14367-note-0006){ref-type="fn"}          PSAR[l](#jth14367-note-0006){ref-type="fn"}          PSAR[l](#jth14367-note-0006){ref-type="fn"}   N/A   NSAR[l](#jth14367-note-0006){ref-type="fn"}          N/A                                           PSAR[l](#jth14367-note-0006){ref-type="fn"}   N/A                                                  N/A                                           PSAR[l](#jth14367-note-0006){ref-type="fn"}          N/A   N/A   N/A                                           N/A                                           N/A
  van Adrichem *et al*., 2014                                                                       PSAR[m](#jth14367-note-0006){ref-type="fn"}          PSAR[m](#jth14367-note-0006){ref-type="fn"}          N/A                                           N/A   N/A                                                  N/A                                           N/A                                           N/A                                                  PSAR[m](#jth14367-note-0006){ref-type="fn"}   PSAR[m](#jth14367-note-0006){ref-type="fn"}          N/A   N/A   PSAR[m](#jth14367-note-0006){ref-type="fn"}   N/A                                           N/A

PSAR, positive significant association reported; NSAR, no significant association reported; N/A, no attempt to report or analyze in the published manuscript; BMI, body mass index; CI, confidence interval; LMWH, low‐molecular‐weight heparin; VTE, venous thromboembolism; OR, odds ratio. ^a^Multivariate logistic regression: *P* = 0.001 for age, *P* = 0.009 for injury type, otherwise reported as showing no association for the relevant prespecified variables. ^b^Descriptive statistics: comparison of percentages only, with Fisher\'s exact test. Associated risk factors highlighted in discussion section. It is notable that no patients in the LMWH group had a VTE event. ^c^Descriptive statistics: comparison of percentages only. Associated risk factors highlighted in Tables [2](#jth14367-tbl-0002){ref-type="table"}, [3](#jth14367-tbl-0003){ref-type="table"}and and discussion section. ^d^Binary logistic regression analysis, noting odds ratio of 1.050 (95% CI, 1.014--1.088; *P* = 0.007) for advancing age, and of 1.201 (95% CI, 1.034--1.395; *P* = 0.016) for high BMI, with no evidence of association between comorbidity, immobilization type or gender and outcome of VTE detected. ^e^Direct comparison of percentages using Fisher\'s exact test, or continuous variables using independent *t*‐test. *P* = 0.011 for age; other identified risk factors all failing to reach predefined significance level. It is notable that the analyzed group is only *n* = 35. ^f^Logistic regression technique described, suggesting the following associations: odds ratio of 3.14 (2.27--4.33) for age \> 50 years, 2.70 (1.66--4.38) for rigid immobilization, 4.11 (1.72--9.86) for non‐weight‐bearing and 1.88 (1.34--2.62) for severe injury. ^g^Descriptive statistics, with *P* values presented for direct comparisons without mention of statistical test. Significant comorbidity, prior VTE and weight‐bearing status were noted to be associated with VTE development (*P* = 0.04, 0.02 and 0.003, respectively.). Logistic regression also performed, highlighting plaster immobilization as an independent predictor of risk (no odds ratio presented). ^h^Logistic regression analysis using univariate and multivariable analysis. Odds ratio of 11.97 (95% CI, 5.14--27.87; *P* \< 0.001) reported for a Charlson score of ≥ 1. No significant association of age with subsequent PE on univariate or multivariate analysis. ^i^Fisher\'s exact test used to compare categorical variable. Higher proportional rate of VTE for patients \> 40 years (*P* = 0.0026). No significant association seen regarding VTE and categorized BMI, comorbidity and exogenous estrogen use. ^j^Multivariable logistic regression: odds ratio of 3.48 (1.11--10.89) for age and 0.16 (0.03--0.80) for soft tissue injury compared to Achilles repair. No association seen between VTE development and gender, immobilization type and length of stay. ^k^Categorical variables assessed using Fisher\'s exact test; age \> 40 years deemed to be associated with higher risk (*P* = 0.016). No association with BMI, comorbidity or prior VTE and no presentation of significant odds ratios on further multivariable analysis. ^l^Multivariable Cox regression: hazard ratios of 1.13 for age, 4.15 for exogenous estrogens, 6.27 (4.18--9.40) for prior VTE, 1.65 (1.12--2.42) for active cancer and 2.68 (1.66--4.33) for increased BMI. ^m^Adjusted odds ratios reported following binary logistic regression; OR of 12.7 (6.6--24.6) for traumatic indication (vs. non‐traumatic), 18.2 (6.2--53.4) for oral contraceptive use, 17.2 (5.4--55.2) for obesity and 23.0 (11.5--44.6) for known thrombophilia.
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We found similar results when an outcome of *symptomatic VTE only* was used within studies. In addition, we performed a *post hoc* analysis excluding studies with less than 90 days follow‐up or excluding studies at high risk of bias. Age continued to be a consistent predictor of VTE risk, highlighted in eight out of ten studies and six out of seven studies, respectively. The effects of these exclusions on other risk factor variables are presented in Tables [S3](#jth14367-sup-0003){ref-type="supplementary-material"} and [S4](#jth14367-sup-0004){ref-type="supplementary-material"}.

We found a few other individual risk factors in this study not included in current scoring systems, but associated with subsequent development of VTE after lower limb immobilization. These included recent air travel (one study) [29](#jth14367-bib-0029){ref-type="ref"} and coagulopathy and peripheral arterial disease (one study) [40](#jth14367-bib-0040){ref-type="ref"}. A single paper looked at the cumulative incidence of clinical risk factors per patient and reported the presence of three or more factors to be significantly associated with development of VTE [35](#jth14367-bib-0035){ref-type="ref"}.

The methodology of reporting individual variables to have no association with subsequent VTE was inconsistent and heterogeneous. Six studies reported no association between gender and VTE [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [31](#jth14367-bib-0031){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [36](#jth14367-bib-0036){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}, five studies reported no association between exogenous estrogen use and VTE [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [33](#jth14367-bib-0033){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, and six studies reported no association between smoking and subsequent VTE [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"}, [40](#jth14367-bib-0040){ref-type="ref"}. Several papers produced conflicting results; six studies reported no association between raised BMI and subsequent risk of VTE [28](#jth14367-bib-0028){ref-type="ref"}, [30](#jth14367-bib-0030){ref-type="ref"}, [32](#jth14367-bib-0032){ref-type="ref"}, [34](#jth14367-bib-0034){ref-type="ref"}, [37](#jth14367-bib-0037){ref-type="ref"}, [38](#jth14367-bib-0038){ref-type="ref"} and one study reported no association with increasing age [31](#jth14367-bib-0031){ref-type="ref"}. These other identified risk factors and all negative associations are reported in Table [4](#jth14367-tbl-0004){ref-type="table"}.

###### 

Other identified individual risk factors and their association with developing VTE

  Study                         Other risk factors shown to be associated with VTE                                                                                                                       Risk factors shown to have no association with VTE                                                                                      Other key findings/authors conclusions
  ----------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gehling *et al*., 1998        NR                                                                                                                                                                       Unable to demonstrate association between cumulative risk factors and thrombosis                                                        Non relevant
  Goel *et al*., 2009           NR                                                                                                                                                                       GenderComorbiditiesBMI                                                                                                                  Given the overall number of fractures, it is difficult to define a specific type as increasing the risk for DVT, but those of the tibial plateau did display a tendency towards higher rates of DVT in the study
  Kock *et al*., 1995           NR                                                                                                                                                                       GenderExogenous estrogenBMI                                                                                                             Treatment procedures involving less immobilisation should be used whenever possible.
  Kujath *et al*., 1993         NR                                                                                                                                                                       SmokingPrior VTEExogenous estrogen                                                                                                      The patients who did not develop a thrombosis had an average of 1.24 risk factors, whereas the patients with thrombosis had an average of 1.96 risk factors. The patients who suffered a thrombosis despite prophylaxis had 2.7 risk factors.
  Zheng *et al*., 2017          NR                                                                                                                                                                       NR                                                                                                                                      The study was not statistically powered to properly cull out any additional potential risk factors that might affect VTE incidence in this population
  Riou *et al*., 2007           Non‐weight‐bearing status (OR, 4.11; 95% CI, 1.72--9.86)                                                                                                                 No association seen on multivariate regression with:○VTE development and cancer○Exogenous estrogen and comorbidity                      Due to a very low incidence of certain variables (cancer, severe diseases and hormonal treatment), the power of the study was not sufficient to identify their roles as potential risk factors. Because the incidence of obesity was not high in study population, the results may not apply to morbidly obese patients
  Hanslow *et al*., 2006        Air travel (multivariate logistic regression)History of rheumatoid arthritis (multivariate logistic regression)                                                          Tourniquet use and mode of anesthesia for those undergoing operative intervention                                                       The incidence of thromboembolic disease after foot and ankle surgery could be higher than that previously reported particularly if a patient has certain risk factors
  Jameson *et al*., 2014        Charlson score of ≥ 1 gives an OR of 11.97 (95% CI, 5.14--27.87; *P* \< 0.001)                                                                                           AgeGender                                                                                                                               Comorbidities elevate the risk of PE and these data can be utilised by clinicians when considering whether to prescribe LMWH for VTE prophylaxis with the attendant risks of the therapy itself borne in mind.
  Makhdom *et al*., 2013        NR                                                                                                                                                                       SmokingBMIExogenous estrogen useSteroid use                                                                                             Patient education is necessary regarding anticipated complications, and early mobilisation should be advocated, especially for patients older than 40 years of age.
  Meek & Tong, 2012             Achilles tendon rupture (descriptive)                                                                                                                                    GenderSoft tissue injuryMethod of immobilizationEmergency department length of staySurgical intervention.                               Increasing age and a diagnosis of Achilles tendon rupture appeared to increase the risk of VTE.
  Patel *et al*., 2012          NR                                                                                                                                                                       Age, comorbidity, previous VTE, BMI, operative intervention                                                                             Congestive heart failure, history of DVT or PE, and obesity might be risk factors, but perhaps the study did not have an adequate number of patients to show this difference.
  Wahlsten *et al*., 2015       Coagulopathy (HR, 2.47; 95% CI, 1.1--5.7)Peripheral arterial disease (HR, 2.34; 95% CI, 1.2--4.6)Non‐steroidal anti‐inflammatory drugs use (HR, 1.3; 95% CI, 1.1--1.6)   SmokingStatin therapy and use of ACE inhibitor medications appeared to convey a protective effect, with HR 0.8 and 0.6, respectively.   Patients with risk factors, especially previous DVT or PE, use of oral contraceptives, and extreme obesity, have an increased risk of DVT/PE that exceeds the risk of DVT/PE in healthy patients undergoing total hip or knee replacement
  van Adrichem *et al*., 2014   The presence of two or more acquired or genetic risk factors in patients with below knee cast immobilization produced an OR of 43.4 (95% CI, 13.4--141.0)                Gender                                                                                                                                  Patients with below‐knee cast immobilisation have a substantially increased risk of venous thrombosis, i.e. a 56‐fold increased risk as compared with patients with no cast, corresponding to an estimated incidence of 1% in the first 3 months after cast application
  Ho & Omari, 2017              Subsequent presentation with symptoms suggestive of DVT (*P* = 0.006)                                                                                                    GenderBMIType of injuryType of immobilizationWeight‐bearing statusSmokingExogenous estrogen useFamily history of VTE                    This pilot study unveiled limitations and logistical issues to be addressed in the future. Notably, the limitations include the small number of patients and the low adherence to attending ultrasound assessment.
  Manafi Rasi *et al*., 2012    Cumulative number of risk factors: presence of three or more risk factors reported as significantly associated with VTE development (*P* = 0.01)                         NR                                                                                                                                      The incidence of DVT significantly increased in the presence of 3 or more risk factors (*P* = 0.01)

ACE, angiotensin‐converting‐enzyme; BMI, body mass index; CI, confidence interval; DVT, deep vein thrombosis; HR, hazard ratio; LMWH, low‐molecular‐weight heparin; NR, not reported or analyzed; OR, odds ratio; PE, pulmonary embolism; VTE, venous thromboembolism.
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Discussion {#jth14367-sec-0015}
==========

In this systematic review of risk factors associated with VTE following temporary lower limb immobilization after injury, we found that only advancing age was consistently highlighted as a risk factor for VTE across the majority of included studies. Injury type showed weaker association, with consistent association across six studies. All studies were deemed to be at moderate or serious risk of bias overall following structured quality assessment. These findings raise questions regarding the reliability of using individual risk factors to determine subsequent VTE risk in this cohort.

Our study is the first systematic review to assess the link between individual risk factors and all VTE (i.e. symptomatic and/or asymptomatic) following temporary lower limb immobilization after injury. This is an important distinction, as our population of interest differs from generic thrombosis datasets; patients with lower limb injury are potentially younger, more active and devoid of comorbidity than those presenting with other forms of VTE [42](#jth14367-bib-0042){ref-type="ref"}. Our study was conducted with robust methodology and was undertaken in accordance with guidelines published by the Centre for Reviews and Dissemination [43](#jth14367-bib-0043){ref-type="ref"}. The protocol was registered in advance with PROSPERO. Clinical experts were involved throughout to assess the validity and applicability of research during the project. We reported descriptive statistics to provide plain insight into the limited evidence base applicable to the subject matter, and the scientific concerns regarding validity of the data.

Our systematic review returned data from randomized controlled trials, prospective cohorts and retrospective health database registries. As such, we were unable to combine data for additional analysis of risk or consider performing an individual patient data meta‐analysis. Despite strict inclusion criteria, the included studies also demonstrated high levels of heterogeneity.

Several studies included patients receiving operative intervention and short inpatient stays. Following the introduction of guidance on thromboprophylaxis to reduce the risk of hospital‐acquired thrombosis, it is reasonable to assume that in a modern healthcare environment most of these patients would receive routine thromboprophylaxis [44](#jth14367-bib-0044){ref-type="ref"}. As such, inclusion of these patients could lead to false reassurance regarding low incidence of VTE. However, we considered patients with a short inpatient stay (\< 5 days) to fit within our scope of interest; initial thromboprophylaxis in hospital may be inadequate in dose and/or duration, and these patients often remain temporarily immobilized for a period of 4--8 weeks in total. Debate also persists about the type and duration of thromboprophylaxis in this setting. Outside randomized trial data, there was significant heterogeneity in thromboprophylaxis regimens by agent, dose and duration. As such, observational cohort studies attempting to link individual risk factors at baseline to subsequent VTE diagnosis are at risk of confounding and selection bias. In addition, some of the larger datasets reported VTE rates related to risk factors without ascertaining which, if any, patients had received prophylaxis. This is a core issue surrounding this topic; definitive VTE event rates, associated risk factors and adverse events cannot be accurately determined by studying a group of patients, however large, in which clinicians have selected higher risk candidates to receive any form of prophylaxis.

Our definition of VTE also masked any subgroup analysis by anatomical location. As such, we were unable to comment on clot burden or whether subsequent VTE occurred in the injured/immobilized limb. Although this latter point is perhaps intuitive, there is additional direct clinical relevance to this question; if VTE is more likely to occur in the affected limb, this suggests a focal issue from a more generalized prothrombotic state and that modification of treatment plans/immobilization strategies could be more beneficial than generic prophylaxis.

All the studies within our review were classed as at moderate or severe risk of bias. As such, any conclusions regarding the influence of risk factors on the subsequent development of VTE are based on weak evidence and have the potential to be inaccurate. In addition, several studies individually report a lack of power to accurately discriminate whether an individual risk factor was not associated with VTE, or whether the sample size precluded statistical association. As such, a lack of significant association within a study cannot be interpreted as direct evidence against the individual risk factor, without further detailed scrutiny.

This is the first systematic review conducted to look directly at individual risk factors increasing the risk of VTE in patients with lower limb injury and immobilization, discharged to an outpatient setting. Previous work has attempted to address a similar issue in patients undergoing elective foot and ankle surgery [45](#jth14367-bib-0045){ref-type="ref"}, [46](#jth14367-bib-0046){ref-type="ref"}, [47](#jth14367-bib-0047){ref-type="ref"}. We consider this to be a different population because of the pathological differences between blunt force and surgical trauma, expert image‐guided reduction and postoperative immobilization regimes.

Advancing age has long been recognized as an established risk factor for VTE [48](#jth14367-bib-0048){ref-type="ref"}. Our findings support this as one of the more reliable individual risk factors, consistently demonstrating association with the likelihood of subsequent VTE. Causation within this study cannot be determined as a result of variable methodology. Indeed, our demonstration of advancing age as a consistent individual risk factor for VTE probably reflects the increasing prothrombotic state seen with aging, irrespective of immobilization. Although we found conflicting evidence on increasing BMI as a risk factor for VTE within this specific cohort of patients, this issue has similar face validity. Increased risk is thought to be related to the prothrombotic state induced by adipocytes and potential reduction in venous flow through larger veins [49](#jth14367-bib-0049){ref-type="ref"}, [50](#jth14367-bib-0050){ref-type="ref"}.

The hypothesis that extent of injury acts as a predictor of VTE risk is in keeping with those studies that report a low VTE incidence in patients with immobilization following soft tissue injury [38](#jth14367-bib-0038){ref-type="ref"}. In addition, there is face validity of the idea of a more severe injury leading to inflammatory cytokines, prothrombotic changes, endothelial activation and subsequent increased predisposition to VTE, in keeping with Virchow\'s triad. However, the challenge remains of decoupling the extent of injury from the type of immobilization; patients with severe fracture patterns are more likely to be placed in stricter and more extensive immobilization. Lastly, we found only two studies identifying cumulative risk with an increased incidence of VTE [35](#jth14367-bib-0035){ref-type="ref"}, [39](#jth14367-bib-0039){ref-type="ref"}. Although this is perhaps intuitive, the supporting data appear limited. This could be confounded by exclusion criteria for high‐risk patients within the trials or the use of thromboprophylaxis for patients with multiple risk factors within observational studies. We did not look to validate the performance of any proposed risk models within this study.

There are no previous systematic reviews on this topic to which our work can be compared. However, several large registries have been recently interrogated in an attempt to derive robust prediction rules for this population, albeit with some methodological concerns. The most recent is the L‐TRiP cast rule, derived from a large population‐based case--control study of over 10 000 cases, including 4446 VTE patients [18](#jth14367-bib-0018){ref-type="ref"}. During this study, the authors performed univariate analysis on 54 candidate predictor variables in an attempt to derive a full, restricted and clinical decision rule for use in this population. Age and BMI featured in all three models, with odds ratios reported on univariate analysis of 3.2 (95% CI, 2.9--3.6) for age ≥ 55 and 3.1 (95% CI, 2.5--3.9) for BMI ≥ 35. No specific candidate variable in this study referred to injury type. However, the extent of immobilization was specifically assessed as a predictor, with odds ratios of 10.7 (95% CI, 4.3--26.6) and 8.7 (95% CI, 5.5--13.7) for complete leg and lower leg casts, respectively, when compared to no cast immobilization. These latter findings perhaps serve as a proxy marker of injury severity and the association with VTE.

The results from the L‐TRiP study are in keeping with this systematic review, although it should be noted that the highest performing individual risk factor on univariate analysis within the L‐TRiP cohort was use of tamoxifen, with an odds ratio of 11.6 (95% CI, 3.3--41.2). We found no evidence from other studies that would support this grade of association.

The findings from this systematic review suggest that although common generic predictors of risk of VTE are relevant to the cohort of interest, there is little consistency within the literature regarding the value of other candidate variables. In addition, there is poor evidence to support the theory of cumulative risk and the existing literature is marred by moderate to serious risk of bias. Our work therefore raises questions regarding the validity of current prediction rules in clinical use created by expert consensus, without robust external validation. There is a pressing need for prospective validation studies in the appropriate cohort of patients to assess the sensitivity and specificity of these rules. Complex scoring systems should also be compared to those which select patients for thromboprophylaxis on the basis of individual strong generic risks (such as advancing age and severe injury) or clinician gestalt.

Our quality assessment overview highlights the limitations of the current literature. As such, there remains a role for further high‐quality prospective observational cohort studies on this topic, particularly looking at the rarer but more severe VTE risks. This research could include pregnant women, those with high‐risk thrombophilia and those using exogenous estrogens. However, such research will have challenges in a health system with national guidance prompting consideration of risk and bespoke prescribing [7](#jth14367-bib-0007){ref-type="ref"}, [44](#jth14367-bib-0044){ref-type="ref"}. In addition, the low frequency of events may result in real difficulty obtaining valid datasets. Such studies would need careful assessment of baseline risk, transparent reporting of thromboprophylaxis and an independently adjudicated, patient‐centered outcome measure.

Conclusions {#jth14367-sec-0016}
===========

We found that increasing age and injury severity only were the individual risk factors most consistently associated with VTE following lower limb immobilization after acute injury. All studies included in the review were deemed to be at moderate or serious risk of bias. Clinicians should be aware of the limited evidence to support individual risk factors in guiding thromboprophylaxis use for this patient cohort.
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